These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 984569)

  • 21. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
    Hellebrekers LJ; Slappendel RJ; van den Brom WE
    Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of a microsample coagulation analyzer, and comparison with existing techniques.
    Carter AJ; Hicks K; Heldman AW; Resar JR; Laird JR; Coombs VJ; Brinker JA; Blumenthal RS
    Cathet Cardiovasc Diagn; 1996 Sep; 39(1):97-102. PubMed ID: 8874958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation assays and platelet aggregation patterns in human, baboon, and canine blood.
    Feingold HM; Pivacek LE; Melaragno AJ; Valeri CR
    Am J Vet Res; 1986 Oct; 47(10):2197-9. PubMed ID: 3096173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated coagulation times of whole blood in normal dogs and dogs with coagulopathies.
    Middleton DJ; Watson AD
    J Small Anim Pract; 1978 Jul; 19(7):417-22. PubMed ID: 692084
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.
    Barnette RE; Shupak RC; Pontius J; Rao AK
    Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a rapid monitoring system to study heparin pharmacokinetics and pharmacodynamics.
    Cipolle RJ; Uden DL; Gruber SA; Jossart GH; Taylor CA; Erdmann GR; Canafax DM
    Pharmacotherapy; 1990; 10(6):367-72. PubMed ID: 2287554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of point-of-care tests for diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK
    J Am Vet Med Assoc; 1999 Sep; 215(6):805-10. PubMed ID: 10496132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of new global clotting assay for monitoring of LMWH treatment: pilot study.
    Makris PE; Pithara E
    Int Angiol; 1998 Jun; 17(2):69-79. PubMed ID: 9754892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques.
    Mabry CD; Thompson BW; Read RC; Campbell GS
    Surgery; 1981 Nov; 90(5):889-95. PubMed ID: 7302842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival.
    Baird CW; Zurakowski D; Robinson B; Gandhi S; Burdis-Koch L; Tamblyn J; Munoz R; Fortich K; Pigula FA
    Ann Thorac Surg; 2007 Mar; 83(3):912-9; discussion 919-20. PubMed ID: 17307433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a bedside activated clotting time test (Hemochron Jr II Signature) with low dose heparin therapy.
    Racioppi L; Quinart A; Biais M; Nouette-Gaulain K; Revel P; Sztark F
    Anaesthesia; 2009 Apr; 64(4):430-4. PubMed ID: 19317710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of prothrombin time and activated partial thromboplastin time in dogs with hepatic disease.
    Badylak SF; Van Vleet JF
    Am J Vet Res; 1981 Dec; 42(12):2053-6. PubMed ID: 7340574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid and accurate direct injection chromatographic method for measuring volatile anesthetics in whole blood of dogs.
    Fleming JT; Pedersoli WM
    Am J Vet Res; 1982 Mar; 43(3):513-6. PubMed ID: 7073068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
    Frank RD; Brandenburg VM; Lanzmich R; Floege J
    Nephrol Dial Transplant; 2004 Jun; 19(6):1552-8. PubMed ID: 15034159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of normal values using an automated coagulation timer for activated coagulation time and its application in dogs with hemophilia.
    Gerber B; Taboada J; Lothrop CD; Busato A; Hosgood G; Goodman SA; Gaschen FP
    J Vet Intern Med; 1999; 13(5):433-6. PubMed ID: 10499726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs.
    Feldman BF; Madewell BR; O'Neill S
    J Am Vet Med Assoc; 1981 Jul; 179(2):151-4. PubMed ID: 7263467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.